Physicochemical Properties
| Molecular Formula | C17H12CLFN6O2S |
| Molecular Weight | 418.832583427429 |
| Exact Mass | 418.041 |
| CAS # | 1279829-87-6 |
| PubChem CID | 71506845 |
| Appearance | Light yellow to yellow solid powder |
| LogP | 2.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 28 |
| Complexity | 644 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | ClC1=CC=C(C(=C1)S(NC1C=CC(=CC=1)C1C=NC2=C(N)NN=C2N=1)(=O)=O)F |
| InChi Key | DDKHTWASHUKHLD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C17H12ClFN6O2S/c18-10-3-6-12(19)14(7-10)28(26,27)25-11-4-1-9(2-5-11)13-8-21-15-16(20)23-24-17(15)22-13/h1-8,25H,(H3,20,22,23,24) |
| Chemical Name | N-[4-(3-amino-2H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]-5-chloro-2-fluorobenzenesulfonamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | SGK1-IN-1 (14n) demonstrates excellent SGK efferosome selectivity with good activity against hSGK2 and moderate activity against hSGK3 with IC50 of 1, 41 nM at 10 μM and 50 μM ATP doses. IN-1 also showed cellular activity in the SGK1 phosphorylation assay of GSK3β in U2OS cells, with an activity of 0.69 μM [2]. |
| References |
[1]. ARYL SULFONOHYDRAZIDES. WO 2013041119 A1. [2]. Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors. ACS Med Chem Lett. 2014 Oct 23;6(1):73-8. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~119.38 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.97 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3876 mL | 11.9380 mL | 23.8760 mL | |
| 5 mM | 0.4775 mL | 2.3876 mL | 4.7752 mL | |
| 10 mM | 0.2388 mL | 1.1938 mL | 2.3876 mL |